Konstantin Adamsky
Director/Board Member at FILAMENT HEALTH CORP.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Benjamin Lightburn | M | 38 | 4 years | |
Jon Conlin | M | 38 | 3 years | |
Lisa Ranken | F | - | 3 years | |
Cordon Anna | F | - | 3 years | |
Ryan Moss | M | - | 3 years | |
Jeff Fellows | M | - | - | |
Andry Tjahyana | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Tom Kineshanko | M | - | 3 years | |
Alex Kotzer | M | 77 |
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | - |
Chris Wagner | M | 55 | 3 years | |
Greg Mills | M | 61 | 1 years | |
Warren Duncan | M | - | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 11 | 91.67% |
Israel | 1 | 8.33% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Konstantin Adamsky
- Personal Network